Fig. 3
From: Activated gut-homing CD8+ T cells for coeliac disease diagnosis on a gluten-free diet
IFN-γ ELISPOT responses (spot forming cells (SFC)/106 PBMC) to the 3-day gluten challenge measured baseline and at day 6 in the different groups of participants. CD, coeliac disease; NR-GFD, disease controls with no clinical response to a GFD; R-GFD, disease controls with a clinical response to a GFD. Lines connect results from individual patients. Centerlines in the box show the median; box limits indicate the 25th and 75th percentiles (IQR); whiskers extend to the highest and lowest observation excluding outliers